Total planned funding: $304,186,693
Clear active filters
Implementing Agency
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
| South Africa | $166,522,884 |
| Nigeria | $41,992,249 |
| Zimbabwe | $28,134,522 |
| Uganda | $26,930,842 |
| Ethiopia | $16,540,690 |
| Côte d'Ivoire | $8,275,170 |
| Dominican Republic | $4,789,001 |
| Rwanda | $2,600,000 |
| Haiti | $1,482,716 |
| Vietnam | $1,327,305 |
| Guyana | $900,000 |
| Indonesia | $800,000 |
| Cameroon | $757,303 |
| Namibia | $633,759 |
| Mozambique | $625,000 |
| Botswana | $550,000 |
| Tanzania | $401,500 |
| Zambia | $275,000 |
| Ukraine | $200,000 |
| Cambodia | $173,311 |
| Malawi | $150,000 |
| Eswatini | $50,000 |
| Lesotho | $40,000 |
| Kenya | $27,441 |
| Asia Regional Program | $8,000 |
| Ghana | $0 |
| Caribbean Region | $0 |
Organizational Types
| Implementing Agency | $304,186,693 |
Program Areas
| Treatment | $157,307,103 |
| Care | $66,665,066 |
| Prevention | $55,880,134 |
| Governance and Systems | $13,721,343 |
| Testing | $10,585,606 |
| Management and Operations | $27,441 |
Budget Codes
| HTXS: Treatment: Adult Treatment | $153,640,863 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $37,712,461 |
| HKID: Care: Orphans and Vulnerable Children | $26,708,059 |
| HVTB: Care: TB/HIV | $21,066,392 |
| HBHC: Care: Adult Care and Support | $14,073,624 |
| HVCT: Testing: HIV Testing and Counseling | $10,585,606 |
| MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $10,036,723 |
| HLAB: Laboratory Infrastructure | $5,712,111 |
| PDCS: Care: Pediatric Care and Support | $4,816,991 |
| OHSS: Health Systems Strengthening | $4,510,994 |
| HVAB: Sexual Prevention: Abstinence/Be Faithful | $3,791,169 |
| PDTX: Treatment: Pediatric Treatment | $3,631,650 |
| HVSI: Strategic Information | $3,498,238 |
| CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $2,509,056 |
| HMBL: Biomedical Prevention: Blood Safety | $1,728,278 |
| IDUP: Prevention: Injecting and Non-Injecting Drug Use | $56,000 |
| HMIN: Biomedical Prevention: Injection Safety | $46,447 |
| HTXD: Treatment: ARV Drugs | $34,590 |
| HVMS: Management and Operations | $27,441 |
Top Partner Programs
University of the Witwatersrand:
$53,102,643
View countries